Skip to main content

KDM4B protects against obesity and metabolic dysfunction.

Citation
Cheng, Y., et al. “Kdm4B Protects Against Obesity And Metabolic Dysfunction.”. Proceedings Of The National Academy Of Sciences Of The United States Of America, pp. E5566-E5575.
Center University of Michigan
Author Yingduan Cheng, Quan Yuan, Laurent Vergnes, Xin Rong, Ji Youn Youn, Jiong Li, Yongxin Yu, Wei Liu, Hua Cai, Jiandie D Lin, Peter Tontonoz, Christine Hong, Karen Reue, Cun-Yu Wang
Keywords KDM4B, Epigenetics, Metabolism, obesity
Abstract

Although significant progress has been made in understanding epigenetic regulation of in vitro adipogenesis, the physiological functions of epigenetic regulators in metabolism and their roles in obesity remain largely elusive. Here, we report that KDM4B (lysine demethylase 4B) in adipose tissues plays a critical role in energy balance, oxidation, lipolysis, and thermogenesis. Loss of KDM4B in mice resulted in obesity associated with reduced energy expenditure and impaired adaptive thermogenesis. Obesity in KDM4B-deficient mice was accompanied by hyperlipidemia, insulin resistance, and pathological changes in the liver and pancreas. Adipocyte-specific deletion of revealed that the adipose tissues were the main sites for KDM4B antiobesity effects. KDM4B directly controlled the expression of multiple metabolic genes, including and Collectively, our studies identify KDM4B as an essential epigenetic factor for the regulation of metabolic health and maintaining normal body weight in mice. KDM4B may provide a therapeutic target for treatment of obesity.

Year of Publication
2018
Journal
Proceedings of the National Academy of Sciences of the United States of America
Volume
115
Issue
24
Number of Pages
E5566-E5575
Date Published
12/2018
ISSN Number
1091-6490
DOI
10.1073/pnas.1721814115
Alternate Journal
Proc. Natl. Acad. Sci. U.S.A.
PMID
29844188
PMCID
PMC6004484
Download citation